Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1346675.RAf-ExVHhxpTGtHzC8OeIOCBQX-fwQpH1w5oslDmtcTnE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1346675.RAf-ExVHhxpTGtHzC8OeIOCBQX-fwQpH1w5oslDmtcTnE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1346675.RAf-ExVHhxpTGtHzC8OeIOCBQX-fwQpH1w5oslDmtcTnE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1346675.RAf-ExVHhxpTGtHzC8OeIOCBQX-fwQpH1w5oslDmtcTnE130_provenance.
- NP1346675.RAf-ExVHhxpTGtHzC8OeIOCBQX-fwQpH1w5oslDmtcTnE130_assertion description "[The amplification rate of C-myc, C-N-ras, C-Ki-ras and C-erbB-2 in ovarian carcinoma were 50%, 44%, 31% and 25% respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1346675.RAf-ExVHhxpTGtHzC8OeIOCBQX-fwQpH1w5oslDmtcTnE130_provenance.
- NP1346675.RAf-ExVHhxpTGtHzC8OeIOCBQX-fwQpH1w5oslDmtcTnE130_assertion evidence source_evidence_literature NP1346675.RAf-ExVHhxpTGtHzC8OeIOCBQX-fwQpH1w5oslDmtcTnE130_provenance.
- NP1346675.RAf-ExVHhxpTGtHzC8OeIOCBQX-fwQpH1w5oslDmtcTnE130_assertion SIO_000772 8585978 NP1346675.RAf-ExVHhxpTGtHzC8OeIOCBQX-fwQpH1w5oslDmtcTnE130_provenance.
- NP1346675.RAf-ExVHhxpTGtHzC8OeIOCBQX-fwQpH1w5oslDmtcTnE130_assertion wasDerivedFrom befree-2016 NP1346675.RAf-ExVHhxpTGtHzC8OeIOCBQX-fwQpH1w5oslDmtcTnE130_provenance.
- NP1346675.RAf-ExVHhxpTGtHzC8OeIOCBQX-fwQpH1w5oslDmtcTnE130_assertion wasGeneratedBy ECO_0000203 NP1346675.RAf-ExVHhxpTGtHzC8OeIOCBQX-fwQpH1w5oslDmtcTnE130_provenance.
- befree-2016 importedOn "2016-02-19" NP1346675.RAf-ExVHhxpTGtHzC8OeIOCBQX-fwQpH1w5oslDmtcTnE130_provenance.